Objective: The present study was designed to evaluate the diabetes induced neuronal damage in the hippocampus of the rat brain. Background: Diabetes mellitus is an endocrine metabolic disorder of impaired carbohydrate, fat and protein metabolisms characterized by chronic hyperglycemia. The neurological consequences of diabetes mellitus in the brain have gained attention most recently. Materials and methods: Male albino rats of Wistar strain, aged 30 days were used. The rats were divided into (A) Normal Control (B) Vehicle Control (C) 15 days of Streptozotocin (STZ), (D) 30 days of STZ, (E) 45 days of STZ, (F) 60 days of STZ diabetic groups (n = 6 in each group). Blood glucose levels and body weight were measured before STZ injection, 2 days after STZ injection and on the day of sacrifi ce. At the end of the experimental period rats were scarifi ed and brains were processed for cresyl violet staining and the number of survived neurons in the hippocampus was quantifi ed. Results: Microscopic examination of cresyl violet stained sections of diabetic rat hippocampus showed signifi cant and reliable changes. There was a signifi cant difference in the number of survived neurons especially in 30 days of STZ, 45 days of STZ and 60 days of STZ diabetic groups compared to normal control group.
Diabetes mellitus is a metabolic syndrome of impaired carbohydrate, fat and protein metabolisms, caused by either lack of insulin secretion or decreased sensitivity of the tissues to insulin, characterized by chronic hyperglycemia. It is associated with chronic complications such as nephropathy, angiopathy, retinopathy and peripheral neuropathy (Biessels et al, 1994) . Many organ systems are affected by diabetes, including the brain, which undergoes changes that may increase the risk of cognitive decline. The effects of diabetes mellitus on brain complications are increasingly recognized (Revsin et al, 2005) .
The prevalence of cognitive dysfunction, depression, and anxiety is about 2-fold higher in diabetic patients than in the general population. Miyata et al (2006) have reported that STZ induced diabetic rodents showed cognitive impairment, depressive and anxiety behavior. Brain damage following cerebral ischemia/reperfusion was worsened distinctly under diabetic conditions (Wang et al, 2001 ). Type 1 diabetes mellitus results in brain disturbances like hypersensitivity to stress, cognitive disturbance, increased risk of stroke and dementia. A STZ model of type 1 diabetes, characterized by low insulin and high plasma glucose levels, affects not only body's overall metabolism but also brain activity (Zhang et al, 2008 ). Ryan has reported that learning and memory capacities are reduced in type 1 diabetes mellitus patients (Ryan, 1988) .
The hippocampus plays a key role in learning and memory activities (Bliss et al, 1993) . Hippocampus is the centre for alterations associated with diabetes in the central nervous system (Saravia et al, 2004) . In a study by Stranahan et al (2008) rats treated with STZ showed hyperglycemia with increased corticosterone and impairments of hippocampal synaptic plasticity and learning. STZ induced diabetic rats showed learning deficits and impaired long-term potentiation in the CA1-fi eld of the hippocampus (Kamal et al, 1999) . In a study by Joghataie et al (2007) diabetes induced a reduction in the spine density of apical dendrites of medial prefrontal cortex neurons only in two-month diabetic rats. Recent studies revealed that STZ induced diabetes signifi cantly reduced the number of proliferating cells in the dentate gyrus of rats by altering the hippocampal synaptic plasticity (Kamal et al, 2000 , Jackson-Guilford et al, 2000 . In this connection in the present study, we studied the amount of damage to the hippocampal neurons using cresyl violet staining in STZ induced experimental diabetes.
Materials and methods
Male albino rats of Wistar strain, aged 30 days, weighing 65-85 g were used. All animals were maintained under 12:12 hour dark: light environment, in institutional animal house. Animals were housed in polypropylene cages; paddy husk was used for bedding. Animals were given water ad libitum, the standard pellets (Hindustan lever) were used for feeding. Research was conducted in compliance with policies and principles contained in the institutional animal ethical committee guidelines. The experimental protocol was approved by the institutional animal ethical committee for experimental clearance (IAEC/KMC/07/2007-2008). Animals were maintained in accordance with the guidelines of government of India for use of laboratory animals.
Animal groups
The rats were divided into (A) Normal Control (NC) (B) Vehicle Control (VC) (C) 15 days of STZ, (D) 30 days of STZ, (E) 45 days of STZ, (F) 60 days of STZ diabetic groups (n = 6 in each group). Rats in NC group were remained undisturbed in their home cage and rats in VC group were fed with vehicle solution (Citric acid buffer, pH 4.5). Diabetes was induced in diabetic group of rats by a single intraperitoneal injection of STZ, and sacrifi ced after 15, 30, 45 and 60 days of diabetic period.
Preparation STZ solution
Fresh STZ solution was prepared in 0.1M citrate buffer (pH 4.5). STZ solution of 10 mg/ml was prepared by dissolving STZ in ice-cold citrate buffer. This is to prevent decomposition of STZ by temperature. The solution was maintained in cold condition by keeping it in a tray of ice cubes.
Induction of experimental diabetes
Rats were fasted the night before STZ drug administration. A single intraperitoneal injection of STZ (Sigma, St, Louis Mo., USA) dissolved in citrate buffer (0.1M, pH 4.5) was delivered within fi ve minutes at a dose of 40 mg/kg body weight. The animals were allowed to drink 5% glucose solution to overcome druginduced hypoglycemia. Vehicle Control animals were injected with the vehicle (Citrate buffer, pH 4.5).
Blood glucose and body weight measurement
Blood was collected from orbital plexus and tail vein of rats and blood glucose levels of rats were measured before STZ injection, 2 days after STZ injection and on the day of sacrifi ce. Blood sugar was estimated with the 'Accu-Chek Advantage Glucose Monitor'. 60-130 mg/dl is the range of normal blood glucose level of rats. Rats having blood glucose levels above 225 mg/dl after the injection of STZ were considered as diabetic and were used for the experiment. Body weights were measured before STZ injection, 2 days after STZ injection and on the day of sacrifi ce.
Histological study of hippocampus Tissue fi xation and processing for paraffi n sectioning
Rats were deeply anesthetized with anesthetic ether, heart was exposed by opening the rib cage. About 100 ml of the heparinized saline was pumped in to the left ventricle through a cannula and right atrium was cut open for the outfl ow of saline and blood. After saline pumping, transcardial perfusion of 300 ml of 4% paraformaldehyde (Prepared in 0.1M citrate buffer) was done. The brains were removed and were post fi xed for 48 hours in the Para formaldehyde. The brains were processed through ascending grades of alcohol 50 % 24 hrs, 70 % 24 hrs, 90 % 12 hrs, 100 % 12 hrs). Clearing of alcohol was done by immersing the brain tissues in xylene for about 1-2 hours. After clearing in xylene paraffi n blocks were made in an embedding bath.
Sectioning the tissues
Coronal sections of 5μm thickness were cut from the dorsal hippocampus using a rotary microtome (Leica RM 2245, Germany). Twenty fi ve to thirty sections from each animal were mounted serially on air dried gelatinized slides. The sections were stained using 0.01 % cresyl violet stain and sections were dehydrated, mounted with DPX.
Cresyl violet staining
Gelatinized slides having brain sections were immersed in xylene solution for 15 minutes and then slides were immersed in ascending grades of alcohols in the following order, absolute alcohol -1 minute, 90 % alcohol -2 minutes, 70 % alcohol -2 minutes, 50 % alcohol -2 minutes. After processing through alcohol, slides were immersed in distilled water for 10 minutes and were stained for 25-30 minutes at temperature 60° in 0.1 % cresyl violet stain and then allowed to cool at room temperature. Stained sections were again immersed in distilled water for 5 minutes and in ascending grades of alcohols (70 %, 90 %) for 2 minutes. Finally, sections were dipped in xylene for clearing and mounted with DPX.
Cell counting
Quantifi cation of neurons in the sub regions of hippocampus (CA1, CA2, CA3, dentate hilus, dentate gyrus) was done using a light microscope under 40X (Magnus, Olympus Pvt. Ltd. New Delhi, India). To avoid manual bias slides from different groups were coded while counting. Ten sections from each rat were considered. The numbers of viable neurons (Neurons with distinct nucleus) were counted. Cells with darkly stained shrunken cell body and cells with fragmented nuclei were excluded from quantifi cation.
Data analysis
Data was analyzed using analysis of variance (ANOVA) with Bonferroni's multiple comparison test as post hoc test (Graph pad prism 2.01 software). Values are expressed as mean ± standard error of mean (SEM). A probability level of p < 0.05 was used as the criterion for statistical signifi cance.
Results

Blood glucose levels
There was no signifi cant difference in the blood glucose levels of NC and VC group rats and the levels were stable throughout the experimental period. The blood glucose levels were as low as in NC and VC groups in the diabetic groups at the beginning of the experiment (before injection of STZ) (NC: 94. (Fig. 1) .
Body weight
The body weights of NC group and diabetic rats group did not differ signifi cantly at the beginning of the experiment (NC: 74 ± 4.17, VC: 76.83 ± 3.44, 15 days of STZ: 75 ± 4.09, 30 days of STZ: (Fig. 2) . (Fig 3-12 
Effect of STZ induced diabetes on the number of surviving neurons of hippocampus
Discussion
Diabetic neuropathy is one of the most common complications of diabetes. Severe as well as chronic hyperglycemia impairs the cerebral blood fl ow and affects the neural structure irreversibly. STZ induced diabetic model results in chronic oxidative stress. DM results in increased formation of free radicals by cellular glucose auto-oxidation with decreased antioxidant potential. In animals and in vitro models of diabetes, hyperglycemia along with the other complications of diabetes causes damage by activating the key pathways of glucose metabolism. Free radical causes cellular damage by initiating apoptosis in neurons and neuroglial cells. Oxidative stress in STZ induced diabetes might not be the only pathogenetic mechanism, other factors like impaired insulin signaling pathway may also be involved in development of the neuropathy (Dagon et al, 2007) .
Neuronal dysfunctions and morphological changes in diabetic hippocampus may also be due to the reduced level of brain derive neurotrophic factor (Wisniewski et al, 2003) . Severity and duration of diabetes bring alterations in the catecholaminergic system in an organized manner and also reduce the dopamine levels in the dopaminergic nigrostriatal system. Reduction in norepinephrine release was observed, in more than 30 days of diabetic duration (Gallego et al, 2003) . STZ induced diabetic rats exhibited increased corticosterone levels (Stranahan et al, 2008) . cAMP-response element binding (CREB) transcription factor is a component of intracellular signaling events that regulate a wide range of biological functions. CREB role has been well-documented in neuronal plasticity and long-term memory formation in the brain (Silva et al, 1998) . Findings from Makimattila et al (2004) and Kumar et al (2010) revealed a signifi cant down regulation of CREB in cerebral cortex, cerebellum, brain stem, hippocampus and hypothalamus and up regulation in corpus striatum of diabetic rats, when compared to controls.
In diabetic brain irregular infl uxes of glutamate or calcium can take place due to reduced expression of calcium binding proteins (Calbindin, Synaptophysin and Syntaxin). Neuronal excitation caused by glutamate and subsequent calcium infl ux into the cell may be the initiating factor for morphological alterations and neuronal cell death in diabetic conditions (Joghataie et al, 2007 , Parihar et al, 2004 . Both types of diabetes causes cerebral alterations by reducing hippocampal synaptic plasticity, abnormal hypothalamic neuropeptide expression, hippocampal astrogliosis, neurotoxicity and changes in glutamate neurotransmission increased circulating corticosterone levels, lack of periodicity, hypersensitivity to stress, and down-regulation of hippocampal glucocorticoid receptors may contribute to the damage. Diabetic patients can exhibit decreased memory and learning (Revsin et al, 2005) .
In STZ induced diabetes the nerve damage is similar to nerve damage in human diabetic neuropathy [Reagan and McEwen, 
2002]
. STZ results in decrease of insulin release by destructing the b-cells of the pancreas. Small amount of residual insulin is still present in the pancreas even after destruction of b cells, and these diabetic animals can survive for several months but, the disease is fatal without treatment (Zhang et al, 2008) . According to the existing data, diabetic effects on the central nervous system are delayed. Previous studies failed to fi nd any changes in neuronal cell number using Nissl staining (Nitta et al, 2002) . Accordingly the present study was designed to further assess the damage infl icted to neurons in the hippocampus in experimental diabetes. Accountable histological alterations were seen in all the regions of hippocampus of diabetic rats when compared to the normal control group. The 30 days diabetic group showed signifi cant changes in the histology of various hippocampal regions. In the hippocampus, neurons were shrunken and darkly stained with a small nucleus. All the sub regions of the hippocampus (CA1, CA2, CA3, dentate hilus, dentate gyrus) showed the most signifi cant changes in 45 and 60 days of diabetes (Rats exposed to chronic diabetes). Our study proved that untreated diabetes mellitus can induce the damage in the central nervous system of the rat within two weeks of diabetic period or earlier. Our results showed that the number of survived neurons in the sub regions of the hippocampus (CA1, CA2, CA3, dentate hilus, dentate gyrus) of diabetic rat brain were decreased to about 75% in 15 days diabetic rats, 60% in 30 days diabetic rats, 35% in 45 days diabetic rats and it was 20% in 60 days diabetic rats compared to controls and prolonged untreated diabetes can lead to severe hippocampal neurodegeneration.
Conclusions
Results from our study indicated that diabetic complications can cause rapid damage to the neurons in the hippocampus of rat brain. The present data in the rat hippocampus may be useful to interpret the functional defi cits of diabetic patients and better management of diabetes.
